USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note F - Operating Leases (Tables)

Note F - Operating Leases (Tables)

12 Months Ended

Jan. 01, 2022

Notes Tables

Assets and Liabilities, Lessee [Table Text Block]

				January 1,				January 2,
Leases		Classification		2022				2021
Assets
ROU operating lease assets, net		Other assets		$	23,789			$	27,947
Total ROU assets				$	23,789			$	27,947

Liabilities
Current:
Operating lease liabilities		Other current liabilities		$	7,080			$	8,616
Non-current:
Operating lease liabilities		Other long-term liabilities			10,215				12,856
Total lease liabilities				$	17,295			$	21,472

Lease, Cost [Table Text Block]

		*Year Ended*

		*2021*				*2020*
Lease cost
Operating lease cost		$	9,585			$	9,411
Total lease cost		$	9,585			$	9,411

		*Year Ended*

		*2021*				*2020*
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases		$	9,506			$	10,410
ROU assets obtained in exchange for new operating lease liabilities		$	5,322			$	6,632
Weighted-average remaining lease term—operating leases		2.76 yrs.				3.13 yrs.
Weighted-average discount rate—operating leases			3.11	%			3.55	%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

Year ending
2022		$	7,481
2023			5,620
2024			3,656
2025			905
2026			348
Thereafter			31
			18,041
Less: imputed interest			(746	)
Present value		$	17,295